Skip to main content

(Approval lapsed) DIBENZYLINE phenoxybenzamine hydrochloride 10mg capsule, USP

Section 19A approved medicine
(Approval lapsed) DIBENZYLINE phenoxybenzamine hydrochloride 10mg capsule, USP
Section 19A approval holder
Boucher and Muir Pty Ltd trading as BNM Group ABN 58 000 140 474
Phone
02 9431 6333
Approved until
Status
Expired
Medicines in short supply/unavailable
DIBENYLINE phenoxybenzamine hydrochloride 10mg capsule jar - ARTG 12980
Indication(s)

Dibenzyline is indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating.

Help us improve the Therapeutic Goods Administration site